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We welcome the recent COVID‐19 tracheostomy National Patient Safety Improvement Program (NatPatSIP) \[[1](#anae15168-bib-0001){ref-type="ref"}\], in providing a consistent and safe approach to tracheostomy in this challenging patient population, while also validating our own hospital\'s strategy. We had already safely undertaken 20 tracheostomies in patients with a mean (SD) age of 54 (8.6) years before the NatPatSIP publication (first case: 24 March 2020; 20 case: 27 April 2020).

We instituted a solely surgeon‐delivered open tracheostomy service, liberating procedural responsibilities from scarce and over‐burdened ITU physicians, while exploiting increased surgeon availability. We believed the surgical technique also offered superior physiological stability, and avoided the greater viral exposure of bronchoscopic‐guided percutaneous procedures. Indeed, we report no intra‐operative oxygen desaturations (S~p~O~2~ \< 90%), loss of airway control or cardiovascular instability, and no confirmed COVID‐19 diagnoses in tracheostomy team members (at the time of writing).

We devised a COVID‐19 tracheostomy Local Safety Standards for Invasive Procedures (LocSSIP), incorporating standardised anaesthetic and surgical techniques (which included tracheal window excision and rescue suture insertion). The LocSSIP was refined and rehearsed using manikin‐based in‐situ simulation, and disseminated via instructional videos. We identified a multidisciplinary group of nine surgeons (general/endocrine, maxillofacial, burns and craniofacial plastics) that agreed to the standardised approach (despite their diverse surgical backgrounds), and established a 24/7 rota for tracheostomy placement and postoperative care.

To increase patient safety, procedures were only undertaken after cessation of proning for \> 72 h and when F~I~O~2~ requirements were low (median 0.35, IQR 0.3--0.4). For staff protection, procedures were only performed in patients with normalising lymphocyte counts (a surrogate for reduced viral load) and after \> 10 days of mechanical ventilation (median (IQR) 16.5 (14.0--19.5) days). The service was delivered safely at both the bed‐side, for uncomplicated procedures (7/20 performed), and in the operating theatres for procedures with predicted difficulty (13/20 performed). For mobile procedures, we used a specially designed portable operating trolley that attached directly to the ICU bed for optimising head and neck position, and high‐intensity head torches to compensate for the lack of theatre lighting.

We highlight the importance of developing a LocSSIP, specific to local resources, agreed and practised (simulation) by relevant personnel. A thorough pre‐tracheostomy briefing, using the LocSSIP, is essential as communication is significantly impaired during these high‐risk procedures once personal protective equipment is applied.
